Research ExplorerScientific StaffEray Gökkurt Publications

Dr.med. ID: 5921880

Eray Gökkurt

graph of relations
Affiliations
1 - 23 out of 23Page size: 50

Publications

  1. 2024

  2. Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial

    Lorenzen, S., Götze, T. O., Thuss-Patience, P., Biebl, M., Homann, N., Schenk, M., Lindig, U., Heuer, V., Kretzschmar, A., Goekkurt, E., Haag, G. M., Riera-Knorrenschild, J., Bolling, C., Hofheinz, R-D., Zhan, T., Angermeier, S., Ettrich, T. J., Siebenhuener, A. R., Elshafei, M., Bechstein, W. O., Gaiser, T., Loose, M., Sookthai, D., Kopp, C., Pauligk, C., Al-Batran, S-E. & AIO and SAKK Study Working Groups, 01.02.2024, In: J CLIN ONCOL. 42, 4, p. 410-420 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Efficacy and quality of life for FOLFOX/bevacizumab +/- irinotecan in first-line metastatic colorectal cancer-final results of the AIO CHARTA trial

    Schmoll, H-J., Mann, J., Meinert, F., Garlipp, B., Borchert, K., Vogel, A., Goekkurt, E., Kaiser, U., Hoeffkes, H-G., Rüssel, J., Kanzler, S., Edelmann, T., Forstbauer, H., Göhler, T., Hannig, C., Hildebrandt, B., Roll, C., Bokemeyer, C., Steighardt, J., Cygon, F., Ibach, S., Stein, A. & Tintelnot, J., 02.2024, In: BRIT J CANCER. 130, 2, p. 233-241 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. Ramucirumab, Avelumab, and Paclitaxel as Second-Line Treatment in Esophagogastric Adenocarcinoma: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial: The Phase 2 RAP (AIO-STO-0218) Nonrandomized Controlled Trial

    Thuss-Patience, P., Högner, A., Goekkurt, E., Stahl, M., Kretzschmar, A., Götze, T., Stocker, G., Reichardt, P., Kullmann, F., Pink, D., Bartels, P., Jarosch, A., Hinke, A., Schultheiß, C., Paschold, L., Stein, A. & Binder, M., 02.01.2024, In: JAMA NETW OPEN. 7, 1, p. e2352830

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2023

  6. Ramucirumab beyond progression plus TAS-102 in patients with advanced or metastatic esophagogastric adenocarcinoma, after treatment failure on a ramucirumab-based therapy

    Goetze, T. O., Stein, A., Lorenzen, S., Habibzada, T., Goekkurt, E., Herhaus, P., Loose, M., Sookthai, D., Brulin, T., Ihrig, K., Pauligk, C. & Al-Batran, S-E., 15.11.2023, In: INT J CANCER. 153, 10, p. 1726-1733 8 p.

    Research output: SCORING: Contribution to journal › Short publication › Research › peer-review

  7. Perioperative FLOT plus ramucirumab for resectable esophagogastric adenocarcinoma: A randomized phase II/III trial of the German AIO and Italian GOIM

    Goetze, T. O., Hofheinz, R-D., Gaiser, T., Schmalenberg, H., Strumberg, D., Goekkurt, E., Angermeier, S., Zander, T., Kopp, H. G., Pink, D., Siegler, G., Schenk, M., de Vita, F., Galizia, G., Maiello, E., Bechstein, W. O., Elshafei, M., Loose, M., Sookthai, D., Brulin, T., Pauligk, C., Homann, N. & Al-Batran, S-E., 01.07.2023, In: INT J CANCER. 153, 1, p. 153-163 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Ramucirumab plus irinotecan / leucovorin / 5-FU versus ramucirumab plus paclitaxel in patients with advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction, who failed one prior line of palliative chemotherapy: the phase II/III RAMIRIS study (AIO-STO-0415)

    Lorenzen, S., Schwarz, A., Pauligk, C., Goekkurt, E., Stocker, G., Knorrenschild, J. R., Illerhaus, G., Dechow, T., Moehler, M., Moulin, J-C., Pink, D., Stahl, M., Schaaf, M., Goetze, T. O. & Al-Batran, S-E., 19.06.2023, In: BMC CANCER. 23, 1, p. 561

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212)

    Stahler, A., Hoppe, B., Na, I-K., Keilholz, L., Müller, L., Karthaus, M., Fruehauf, S., Graeven, U., Fischer von Weikersthal, L., Goekkurt, E., Kasper, S., Kind, A. J., Kurreck, A., Alig, A. H. S., Held, S., Reinacher-Schick, A., Heinemann, V., Horst, D., Jarosch, A., Stintzing, S., Trarbach, T. & Modest, D. P., 01.06.2023, In: J CLIN ONCOL. 41, 16, p. 2975-2987 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial

    Shitara, K., Di Bartolomeo, M., Mandala, M., Ryu, M-H., Caglevic, C., Olesinski, T., Chung, H. C., Muro, K., Goekkurt, E., McDermott, R. S., Mansoor, W., Wainberg, Z. A., Shih, C-S., Kobie, J., Nebozhyn, M., Cristescu, R., Cao, Z. A., Loboda, A. & Özgüroğlu, M., 06.2023, In: J IMMUNOTHER CANCER. 11, 6, e006920.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. Combining Poly-(ARD-Ribose) Polymerase and Programmed Cell Death Protein 1 Inhibition in a Patient with Esophagogastric Adenocarcinoma

    Artzenroth, J. C., Tintelnot, J., Haag, G. M., Gökkurt, E., Steffens, J. & Stein, A., 2023, In: ONCOL RES TREAT. 46, 7-8, p. 320-325 6 p.

    Research output: SCORING: Contribution to journal › Case report › Research › peer-review

  12. Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma-a phase II trial of the AIO study group (AIO STO 0321)

    Tintelnot, J., Stein, A., Al-Batran, S-E., Ettrich, T., Götze, T., Grün, B., Haag, G. M., Heuer, V., Hofheinz, R-D., Homann, N., Bröring, T. S., Cruz, M. S., Kurreck, A., Lorenzen, S., Moosmann, N., Müller, C., Schuler, M., Siegler, G., Binder, M. & Gökkurt, E., 2023, In: FRONT ONCOL. 13, p. 1272175

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  13. 2022

  14. FLOT Versus FLOT/Trastuzumab/Pertuzumab Perioperative Therapy of Human Epidermal Growth Factor Receptor 2-Positive Resectable Esophagogastric Adenocarcinoma: A Randomized Phase II Trial of the AIO EGA Study Group

    Hofheinz, R-D., Merx, K., Haag, G. M., Springfeld, C., Ettrich, T., Borchert, K., Kretzschmar, A., Teschendorf, C., Siegler, G., Ebert, M. P., Goekkurt, E., Mahlberg, R., Homann, N., Pink, D., Bechstein, W., Reichardt, P., Flach, H., Gaiser, T., Battmann, A., Oduncu, F. S., Loose, M., Sookthai, D., Pauligk, C., Göetze, T. O. & Al-Batran, S-E., 10.11.2022, In: J CLIN ONCOL. 40, 32, p. 3750-3761 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. Efficacy of Ipilimumab vs FOLFOX in Combination With Nivolumab and Trastuzumab in Patients With Previously Untreated ERBB2-Positive Esophagogastric Adenocarcinoma: The AIO INTEGA Randomized Clinical Trial

    Stein, A., Paschold, L., Tintelnot, J., Goekkurt, E., Henkes, S-S., Simnica, D., Schultheiss, C., Willscher, E., Bauer, M., Wickenhauser, C., Thuss-Patience, P., Lorenzen, S., Ettrich, T., Riera-Knorrenschild, J., Jacobasch, L., Kretzschmar, A., Kubicka, S., Al-Batran, S-E., Reinacher-Schick, A., Pink, D., Sinn, M., Lindig, U., Hiegl, W., Hinke, A., Hegewisch-Becker, S. & Binder, M., 01.08.2022, In: JAMA ONCOL. 8, 8, p. 1150-1158 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)

    Hartlapp, I., Valta-Seufzer, D., Siveke, J. T., Algül, H., Goekkurt, E., Siegler, G., Martens, U. M., Waldschmidt, D., Pelzer, U., Fuchs, M., Kullmann, F., Boeck, S., Ettrich, T. J., Held, S., Keller, R., Anger, F., Germer, C. T., Stang, A., Kimmel, B., Heinemann, V., Kunzmann, V. & German Pancreatic Cancer Group (AIO-PAK) and NEOLAP investigators, 08.2022, In: ESMO OPEN. 7, 4, p. 100552

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212)

    Modest, D. P., Karthaus, M., Fruehauf, S., Graeven, U., Müller, L., König, A. O., Fischer von Weikersthal, L., Caca, K., Kretzschmar, A., Goekkurt, E., Haas, S., Kurreck, A., Stahler, A., Held, S., Jarosch, A., Horst, D., Reinacher-Schick, A., Kasper, S., Heinemann, V., Stintzing, S. & Trarbach, T., 01.01.2022, In: J CLIN ONCOL. 40, 1, p. 72-82 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Platinum-Based Chemotherapy in Locally Advanced or Metastatic Pancreatic Ductal Adenocarcinoma: Summary of Evidence and Application in Clinical Practice

    Reinacher-Schick, A., Arnold, D., Venerito, M., Goekkurt, E., Kraeft, A-L. & Seufferlein, T., 2022, In: ONCOL RES TREAT. 45, 12, p. 752-763 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  19. Translational analysis and final efficacy of the AVETUX trial - Avelumab, cetuximab and FOLFOX in metastatic colorectal cancer

    Tintelnot, J., Ristow, I., Sauer, M., Simnica, D., Schultheiß, C., Scholz, R., Goekkurt, E., von Wenserski, L., Willscher, E., Paschold, L., Lorenzen, S., Riera-Knorrenschild, J., Depenbusch, R., Ettrich, T. J., Dörfel, S., Al-Batran, S-E., Karthaus, M., Pelzer, U., Hinke, A., Bauer, M., Massa, C., Seliger, B., Wickenhauser, C., Bokemeyer, C., Hegewisch-Becker, S., Binder, M. & Stein, A., 2022, In: FRONT ONCOL. 12, 993611.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. 2021

  21. Landscape of Biomarkers and Actionable Gene Alterations in Adenocarcinoma of GEJ and Stomach-A Real World Data Analysis

    Hempel, L., de Oliveira, J. V., Gaumann, A., Milani, V., Schweneker, K., Schenck, K., Fleischmann, B., Philipp, P., Mederle, S., Garg, A., Piehler, A., Gandorfer, B., Schick, C., Kleespies, A., Sellmann, L., Bartels, M., Goetze, T. O., Stein, A., Goekkurt, E., Pfitzner, L., Robert, S. & Hempel, D., 03.09.2021, In: CANCERS. 13, 17, 4453.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Pembrolizumab plus chemotherapy versus chemotherapy alone for first-line treatment of advanced oesophageal cancer (KEYNOTE-590): a randomised, placebo-controlled, phase 3 study

    Sun, J-M., Shen, L., Shah, M. A., Enzinger, P., Adenis, A., Doi, T., Kojima, T., Metges, J-P., Li, Z., Kim, S-B., Cho, B. C., Mansoor, W., Li, S-H., Sunpaweravong, P., Maqueda, M. A., Goekkurt, E., Hara, H., Antunes, L., Fountzilas, C., Tsuji, A., Oliden, V. C., Liu, Q., Shah, S., Bhagia, P., Kato, K. & KEYNOTE-590 Investigators, 28.08.2021, In: LANCET. 398, 10302, p. 759-771 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. PD-L1 targeting and subclonal immune escape mediated by PD-L1 mutations in metastatic colorectal cancer

    Stein, A., Simnica, D., Schultheiß, C., Scholz, R., Tintelnot, J., Gökkurt, E., von Wenserski, L., Willscher, E., Paschold, L., Sauer, M., Lorenzen, S., Riera-Knorrenschild, J., Depenbusch, R., Ettrich, T. J., Dörfel, S., Al-Batran, S-E., Karthaus, M., Pelzer, U., Waberer, L., Hinke, A., Bauer, M., Massa, C., Seliger, B., Wickenhauser, C., Bokemeyer, C., Hegewisch-Becker, S. & Binder, M., 07.2021, In: J IMMUNOTHER CANCER. 9, 7, e002844.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report

    Velthaus, J-L., Iglauer, P., Simon, R., Bokemeyer, C., Bannas, P., Beumer, N., Imbusch, C. D., Goekkurt, E. & Loges, S., 2021, In: ONCOL RES TREAT. 44, 9, p. 495-502 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. 2020

  26. Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial

    Shitara, K., Van Cutsem, E., Bang, Y-J., Fuchs, C., Wyrwicz, L., Lee, K-W., Kudaba, I., Garrido, M., Chung, H. C., Lee, J., Castro, H. R., Mansoor, W., Braghiroli, M. I., Karaseva, N., Caglevic, C., Villanueva, L., Goekkurt, E., Satake, H., Enzinger, P., Alsina, M., Benson, A., Chao, J., Ko, A. H., Wainberg, Z. A., Kher, U., Shah, S., Kang, S. P. & Tabernero, J., 01.10.2020, In: JAMA ONCOL. 6, 10, p. 1571-1580 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Ipilimumab or FOLFOX with Nivolumab and Trastuzumab in previously untreated HER2-positive locally advanced or metastatic EsophagoGastric Adenocarcinoma - the randomized phase 2 INTEGA trial (AIO STO 0217)

    Tintelnot, J., Goekkurt, E., Binder, M., Thuss-Patience, P., Lorenzen, S., Knorrenschild, J. R., Kretzschmar, A., Ettrich, T., Lindig, U., Jacobasch, L., Pink, D., Al-Batran, S-E., Hinke, A., Hegewisch-Becker, S., Nilsson, S., Bokemeyer, C. & Stein, A., 01.06.2020, In: BMC CANCER. 20, 1, p. 503

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. 2018

  29. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial

    Shitara, K., Özgüroğlu, M., Bang, Y-J., Bartolomeo, M. D., Mandalà, M., Ryu, M-H., Fornaro, L., Olesiński, T., Caglevic, C., Chung, H. C., Muro, K., Goekkurt, E., Mansoor, W., McDermott, R. S., Shacham-Shmueli, E., Chen, X., Mayo, C., Kang, S. P., Ohtsu, A., Fuchs, C. S. & KEYNOTE-061 investigators, 14.07.2018, In: LANCET. 392, 10142, p. 123-133 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review